Page 1 of Clinical Trials for Chiesi Pharmaceuticals Inc. [SPONSOR-COLLABORATORS], 10 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: November 17, 2011
Condition(s): Chronic Obstructive Pulmonary Disease
2
Completed
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment
Last Updated: May 17, 2012
Condition(s): Alzheimer's Disease
3
Completed
Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects
Last Updated: November 17, 2011
Condition(s): Alzheimer's Disease
4
Completed
Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects
Last Updated: May 18, 2012
Condition(s): Alzheimer's Disease
5
Enrolling by invitation
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)
Last Updated: May 17, 2012
Condition(s): Alzheimer's Disease
6
Completed
Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects
Last Updated: November 17, 2011
Condition(s): Alzheimer's Disease
7
Enrolling by invitation
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase
Last Updated: May 17, 2012
Condition(s): Alzheimer's Disease
8
Completed
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Last Updated: August 24, 2010
Condition(s): Chronic Obstructive Pulmonary Disease
9
Completed
Dose Finding Study of CHF 4226 for Treating Patients With COPD
Last Updated: August 24, 2010
Condition(s): Chronic Obstructive Pulmonary Disease
10
Completed
Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers
Last Updated: March 26, 2009
Condition(s): Chronic Obstructive Pulmonary Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Chiesi+Pharmaceuticals+Inc.

Page 1 of Clinical Trials for Chiesi Pharmaceuticals Inc. [SPONSOR-COLLABORATORS], 10 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About